Magnetic Activated Cell Sorting in Artificial Insemination With Donor Sperm
MACSIAD
Application of Magnetic Activated Cell Sorting (MACS) of Spermatozoa in Artificial Insemination Cycles With Donor Sperm (AID)
1 other identifier
interventional
130
1 country
1
Brief Summary
The aim of this study is to analyse the efficacy of MACS technique for the selection of spermatozoa and its effects on implantation, pregnancy and miscarriage rate. This study will be performed by two IVI clinics (IVI Sevilla and IVI Madrid) with the purpose of finding new techniques that allow us to better select spermatozoa and improve the results of assisted reproduction techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
April 13, 2018
CompletedFirst Submitted
Initial submission to the registry
April 24, 2018
CompletedFirst Posted
Study publicly available on registry
September 6, 2018
CompletedSeptember 6, 2018
September 1, 2018
3 months
April 24, 2018
September 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pregnancy rate
The number of pregnancies confirmed by ultrasound divided by the number of artificial insemination cycles. Pregnancy is confirmed by ultrasound examination.
Ultrasound examination is performed 5 weeks after artificial insemination. Pregnancy rate is calculated during the phase of data analysis.
Implantation rate
The number of positive results of beta human chorionic gonadotropin (hCG) test divided by the number of artificial insemination cycles. Implantation is confirmed through the analysis of beta hCG in blood.
The beta hCG analysis is performed 15 days after artificial insemination. Implantation rate is calculated during the phase of data analysis.
Live birth rate
The number of live births divided by the number of artificial insemination cycles
Live births are assessed at delivery (end of pregnancy period). Live birth rate is calculated during the phase of data analysis
Secondary Outcomes (5)
Sperm cell concentration
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cell motility
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cell morphology
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm cells vitality
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Sperm sample volume
This parameter is assessed when preparing the sample for artificial insemination (one hour before artificial insemination).
Study Arms (2)
MACS is applied to the sperm sample
EXPERIMENTALPrevious to the AID technique, the sperm sample undergoes capacitation through Percoll density gradient and MACS
MACS is not applied to the sperm sample
NO INTERVENTIONPrevious to the AID technique, MACS only undergoes capacitation through Percoll density gradient, but not MACS technique
Interventions
MACS is a technique that allow us to tag and detect apoptotic spermatozoa. These apoptotic spermatozoa have phosphatidylserine in their membranes, so we add magnetic beads with Annexin V, which binds specifically to phosphatidylserine. The spermatozoa are then tagged and can be retained in a magnetic field, allowing us to collect just the non-apoptotic spermatozoa.
Eligibility Criteria
You may qualify if:
- Women who undergo artificial insemination with donor sperm
- Signing an informed consent form to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
IVI Sevilla
Seville, 41011, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2018
First Posted
September 6, 2018
Study Start
November 7, 2017
Primary Completion
February 16, 2018
Study Completion
April 13, 2018
Last Updated
September 6, 2018
Record last verified: 2018-09